SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Heart Attacks, Cancer and strokes. Preventative approaches
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ig who wrote (38646)2/1/2024 7:54:30 AM
From: Stan   of 39319
 
I'll keep up the dosages for as long as the bottle lasts. If I think it's helping I'll try another. In fact, your article appears to my layman's understanding to provide some hope.

3.1. Human Study

In experiment 1, with 160 subjects with SVOs [symptomatic vitreous opacities], we compared the results of MFEs [mixed fruit enzymes] in treating SVOs after three months. The rates of disappearance in SVOs were 55%, 62.5%, and 70% in the 1-, 2-, and 3- capsule groups after three months (p < 0.05), respectively ( Table 1). Therefore, we demonstrated that SVOs should be broken down and absorbed by MFEs. Moreover, the outcomes showed a dose-dependent manner. In other words, the higher amounts of fruit enzyme in the capsules, the stronger the hydrolytic and proteolytic ability for dissolving SVOs. If the patients took at least one capsule of MFEs, SVOs might significantly disappear. Further, the subjects in the placebo were given vitamin C for three months; however, SVOs apparently persisted (p > 0.05).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News